Diabetic nephropathy among Mexican Americans

Clinical Nephrology

Volumn 77, Issue 4, 2012, Pages 332-344

  Debnath, Subrata ^a   Thameem, Farook ^a   Alves, Tahira ^a,b   Nolen, Jacqueline ^a   Hania, Al Shahrouri ^a,b   Bansal, Shweta ^a   Abboud, Hanna E ^a,b   Fanti, Paolo ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Diabetes; Epidemiology; Mexican american; Nephropathy

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNICITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HEALTH DISPARITY; HEMODIALYSIS; HISPANIC; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; LIFESTYLE; MACROALBUMINURIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OBESITY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SOCIAL STATUS; UREMIA;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MEXICAN AMERICANS; OBESITY; POVERTY; PREVALENCE; RISK FACTORS; TEXAS;

EID: 84861494927     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107487     Document Type: Article

References (140)

1. Tiwari SC. Studies of crossing between Indians and Europeans. Ann Hum Genet. 1963; 26: 219-227. doi:10.1111/j.1469-1809.1963.tb01978.x PubMed
2. U.S. Census Bureau. Hispanic Heritage Month 2009, in Facts for Features, U.S.C.B. News, Editor. 2009: Washington, D.C.
3. Palmer Alves T, Lewis J. Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol. 2010; 74 (Suppl 1): S72-S77. PubMed
4. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. 1997 Federal Register Notice, October 30, 1997 cited; Available from: http://www.whitehouse.gov/omb/fedr eg_1 9 97standards/.
5. Office of Extramural Research. O. NIH Policy on reporting race and ethnicity data: Subjects in clinical research. 2001 August 8, 2001 cited; Available from: http://grants.nih.gov/grants/guide/notice-files/not-od-01-053.html.
6. Stern MP, Mitchell BD. Diabetes in Hispanic Americans, U.S.D.o.H.a.H. Services, Editor. The National Diabetes Information Clearinghouse (NDIC); 1995. p. 631-660.
7. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290: 1884-1890. doi:10.1001/jama.290.14.1884 PubMed
8. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of Type II diabetes mellitus in Mexican Americans. Diabetes Care. 1991; 14: 102-108. doi:10.2337/diacare.1 4.2.102 PubMed
9. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984, in Diabetes Care. 1991. p. 628-638.
10. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21: 518-524. doi:10.2337/diacare.21.4.518 PubMed
11. Black SA, Ray LA, Markides KS. The prevalence and health burden of self-reported diabetes in older Mexican Americans: findings from the Hispanic established populations for epidemiologic studies of the elderly. Am J Public Health. 1999; 89: 546-552. doi:10.2105/AJPH.89.4.546 PubMed
12. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol. 1990; 131: 423-433. PubMed
13. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol. 1989; 129: 295-311. PubMed
14. Lindeman RD, Romero LJ, Hundley R, Allen AS, Liang HC, Baumgartner RN, Koehler KM, Schade DS, Garry PJ. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. Diabetes Care. 1998; 21: 959-966. doi:10.2337/diacare. 21.6.959 PubMed
15. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of endstage renal disease in Mexican Americans. Am J Epidemiol. 1988; 127: 135-144. PubMed
16. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, Patterson JK, Klein R. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989; 12: 530-536. doi:10.2337/diacare.12.8.530 PubMed
17. Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care. 2001; 24: 454-459. doi:10.2337/diacare.24.3.454 PubMed
18. Sievers ML, Fisher JR. Diabetes in North American Indians., U.S.D.o.H.a.H. Services, Editor. National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases. Bethesda: National Institutes of Health, Public Health Service; 1985. p. 72.
19. Gardner LI Jr, Stern MP, Haffner SM, Gaskill SP, Hazuda HP, Relethford JH, Eifler CW. Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from native American sources. Diabetes. 1984; 33: 86-92. doi:1 0.2337/diabetes.33.1.86 PubMed
20. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD; Diabetic Renal Disease Study Group. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med. 1996; 335: 1636-1642. doi:10 .1 056/NEJM199611283352203 PubMed
21. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int. 1989; 35: 681-687. doi:10.1038/ki.1989.39 PubMed
22. Zhang J, Markides KS, Lee DJ. Health status of diabetic Mexican Americans: results from the Hispanic HANES. Ethn Dis. 1991; 1: 273-279. PubMed
23. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298: 2038-2047. doi:10.1001/jama.298.17.2038 PubMed
24. Otiniano ME, Black SA, Ray LA, Du X, Markides KS. Correlates of diabetic complications in Mexican-American elders. Ethn Dis. 2002; 12: 252-258. PubMed
25. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005; 16: 180-188. doi:10.1681/ASN.2004070539 PubMed
26. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002; 13: 1034-1039. PubMed
27. Garza R, Medina R, Basu S, Pugh JA. Predictors of the rate of renal function decline in non-insu lin-dependent diabetes mellitus. Am J Nephrol. 1997; 17: 59-67. doi:10.1159/000169073 PubMed
28. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H et al. ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010; 376: 419-430. doi:10.1016/S0140-6736(10)60576-4 PubMed
29. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J; National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000; 36: 646-661. doi:10.1053/ajkd.2000.16225 PubMed
30. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002; 61: 2165-2175. doi:10.1046/j.1 523-1755.2002.0 035 6.x PubMed
31. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69: 2057-2063. doi:10.1038/sj.ki.5000377 PubMed
32. Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment co-existing with NIDDM (NEFRON) 11). Diabetes Care. 2009; 32: 1497-1502. doi:10.2337/dc08-2186 PubMed
33. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M. Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006; 332: 1426. doi:10.1136/bmj.38814.566019.2F PubMed
34. U.S. Renal Data System. Incidence & Prevalence. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2009. p. 231-240.
35. U.S. Renal Data System. Incidence & Prevalence, in Atlas of End-Stage Renal Disease in the United States. 2010, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD. p. 253-266.
36. Pugh JA, Medina RA, Cornell JC, Basu S. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes. 1995; 44: 1375-1380. doi:10.2337/diabetes.44.12.1375 PubMed
37. U.S. Renal Data System. Incidence & Prevalence, in Atlas of End-Stage Renal Disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD. 2006. p. 231-240.
38. U.S. Renal Data System. A. Incidence of reported ESRD, in Atlas of End-Stage Renal Disease in the United States. 2009, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD. p. 429-452.
39. Murthy BV, Molony DA, Stack AG. Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol. 2005; 16: 782-790. doi:10.1681/AS N.2 004080627 PubMed
40. Pugh JA, Tuley MR, Basu S. Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis. 1994; 23: 803-807. PubMed
41. Frankenfield DL, Rocco MV, Roman SH, McClellan WM. Survival advantage for adult Hispanic hemodialysis patients? Findings from the endstage renal disease clinical performance measures project. J Am Soc Nephrol. 2003; 14: 180-186. doi:10.1097/01.ASN.0000037400.83593.E6 PubMed
42. Frankenfield DL, Krishnan SM, Ashby VB, Shearon TH, Rocco MV, Saran R. Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States. Am J Kidney Dis. 2009; 53: 647-657. doi:10 .1053/j.ajkd.2008.10.049 PubMed
43. Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, Mehrotra R, Nissenson AR, Arah OA, Greenland S, Kalantar-Zadeh K. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis. 2011; 58: 574-582. doi:10.1053/j.ajkd.2011.03.023 PubMed
44. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005; 46: 489-500. doi:10.1053/j.ajkd.2 005.05.020 PubMed
45. Pugh JA. Diabetic nephropathy and end-stage renal disease in Mexican Americans. Blood Purif. 1996; 14: 286-292. doi:10.1159/000170275 PubMed
46. Brorsson C, Pociot F. Genetics of diabetic nephropathy in diverse ethnic groups. Contrib Nephrol. 2011; 170: 8-18. doi:10.1159/000324937 PubMed
47. Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol. 2007; 2: 1306-1316. doi:10.2215/CJN.02560607 PubMed
48. Knowler WC, Coresh J, Elston RC, Freedman BI, Iyengar SK, Kimmel PL, Olson JM, Plaetke R, Sedor JR, Seldin MF; Family Investigation of Nephropathy and Diabetes Research Group. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications. 2005; 19: 1-9. doi:10.1016/j.jdiacomp. 2003.12.007 PubMed
49. Puppala S, Arya R, Thameem F, Arar NH, Bhandari K, Lehman DM, Schneider J, Fowler S, Farook VS, Diego VP, Almasy L, Blangero J, Stern MP, Duggirala R, Abboud HE. Genotype by diabetes interaction effects on the detection of linkage of glomerular filtration rate to a region on chromosome 2q in Mexican Americans. Diabetes. 2007; 56: 2818-2828. doi:10.2337/db06-0984 PubMed
50. MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG, Dyke B, Haffner SM, Henkel RD, Hixson JE, Kammerer CM, Mahaney MC, Mitchell BD, Rainwater DL, Samollow PB, Sharp RM, VandeBerg JL, Williams JT. Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev. 1999; 57: 59-65. doi:10.1 111/j.1753-4887.1999.tb01790.x PubMed
51. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2. 1992; p. 1-35. PubMed
52. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS et al. Family Investigation of Nephropathy and Diabetes Research Group. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes. 2007; 56: 1577-1585. doi:10.2337/db06-1154 PubMed
53. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ et al. Family Investigation of Nephropathy and Diabetes Research Group. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes. 2008; 57: 235-243. doi:10.2337/db07-0313 PubMed
54. Bhandari KDR, Kawalitt I, Arya R, Fowler S, Pergola PE, Plaetke R, Almasy L, O'Connell P, Blangero J, Abboud HE, Stern MP. Genome-wide search for albuminuria susceptibility genes in Mexican Americans. Diabetes. 2001; 50: A240-A241.
55. Lehman DM, Leach RJ, Johnson-Pais T, Hamlington J, Fowler S, Almasy L, Duggirala R, Stern MP, Abboud HE. Evaluation of tight junction protein 1 encoding zona occludens 1 as a candidate gene for albuminuria in a Mexican American population. Exp Clin Endocrinol Diabetes. 2006; 114: 432-437. doi:10.1055/s-2006-924328 PubMed
56. Thameem F, He X, Voruganti VS, Nath SD, Fanti P, Blangero J, Maccluer JW, Comuzzie AG, Arar NH, Abboud HE. Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans. Kidney Blood Press Res. 2009; 32: 200-204. doi:10.1159/000225943 PubMed
57. Arar N, Nath S, Thameem F, Bauer R, Voruganti S, Comuzzie A, Cole S, Blangero J, MacCluer J, Abboud H. Genome-wide scans for microalbuminuria in Mexican Americans: the San Antonio Family Heart Study. Genet Med. 2007; 9: 80-87. doi:10.1097/GIM.0b013e31803068ec PubMed
58. Arar NH, Voruganti VS, Nath SD, Thameem F, Bauer R, Cole SA, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE. A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol Dial Transplant. 2008; 23: 3184-3191. doi:10.1093/ndt/gfn215 PubMed
59. Chu AY, Parekh RS, Astor BC, Coresh J, Berthier-Schaad Y, Smith MW, Shuldiner AR, Kao WH. Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Med Genet. 2009; 10: 108. doi:10.1 18 6/1 4 71-2350-10-108 PubMed
60. Kim S, Abboud HE, Pahl MV, Tayek J, Snyder S, Tamkin J, Alcorn H Jr, Ipp E, Nast CC, Elston RC, Iyengar SK, Adler SG. Examination of association with candidate genes for diabetic nephropathy in a Mexican American population. Clin J Am Soc Nephrol. 2010; 5: 1072-1078. doi:10.2215/CJN.0 6550909 PubMed
61. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet. 1999; 21: 213-215. doi:10.1038/6002 PubMed
62. Parra EJ, Below JE, Krithika S, Valladares A, Barta JL, Cox NJ, Hanis CL, Wacher N, Garcia-Mena J, Hu P, Shriver MD, Kumate J, McKeigue PM, Escobedo J, Cruz M; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia. 2011; 54: 2038-2046. doi:10.1007/s00125-011-2172-y PubMed
63. Below JE, Gamazon ER, Morrison JV, Konkashbaev A, Pluzhnikov A, McKeigue PM, Parra EJ, Elbein SC, Hallman DM, Nicolae DL, Bell GI, Cruz M, Cox NJ, Hanis CL. Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia. 2011; 54: 2047-2055. doi:10.1007/s00125-011-2188-3 PubMed
64. Hayes MG, Pluzhnikov A, Miyake K, Sun Y, Ng MC, Roe CA, Below JE, Nicolae RI, Konkashbaev A, Bell GI, Cox NJ, Hanis CL. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes. 2007; 56: 3033-3044. doi:10.2337/db07-0482 PubMed
65. del Bosque-Plata L, Aguilar-Salinas CA, Tusié-Luna MT, Ramírez-Jiménez S, Rodríguez-Torres M, Aurón-Gómez M, Ramírez E, Velasco-Pérez ML, Ramírez-Silva A, Gómez-Pérez F, Hanis CL, Tsuchiya T, Yoshiuchi I, Cox NJ, Bell GI. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab. 2004; 81: 122-126. doi:10.1016/j.ymgme. 2003.10.005 PubMed
66. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzch H, Schröder HE et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet. 1996; 13: 161-166. doi:10. 1038/ng0696-161 PubMed
67. Wang J, Geiss LS, Cheng YJ, Imperatore G, Saydah SH, James C, Gregg EW. Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008. Diabetes Care. 2011; 34: 1579-1581. doi:10.2337/dc11-0178 PubMed
68. Ostchega Y, Yoon SS, Hughes J et al. Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005-2006. NCHS Data Brief, 2008(3). p. 1-8.
69. Haffner SM, Mitchell BD, Stern MP, Hazuda HP. Macrovascular complications in Mexican Americans with type II diabetes. Diabetes Care. 1991; 14: 665-671. doi:10.2337/diacare.14.7.665 PubMed
70. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb. 1993; 13: 205-210. doi:10.1161/01.ATV.13.2.205 PubMed
71. Cowie CC, Harris MI. Physical and Metabolic Characteristics of Persons with Diabetes, U.S.D.o.H.a.H. Services, Editor. The National Diabetes Information Clearinghouse (NDIC); 1995. p. 117-164.
72. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988-1994. Am J Prev Med. 2002; 22: 42-48. doi:10.1016/S0749-3797(01)00399-3 PubMed
73. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991; 324: 733-739. doi:10.1056/NEJM199103143241105 PubMed
74. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 1990; 39: 1430-1435. doi:10.2337/diabetes.39.11.1430 PubMed
75. Satish S, Markides KS, Zhang D, Goodwin JS. Factors influencing unawareness of hypertension among older Mexican Americans. Prev Med. 1997; 26: 645-650. doi:10.1006/pmed.1997.0232 PubMed
76. Satish S, Stroup-Benham CA, Espino DV, Markides KS, Goodwin JS. Undertreatment of hypertension in older Mexican Americans. J Am Geriatr Soc. 1998; 46: 405-410. PubMed
77. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-313. PubMed
78. Fischer MJ, Go AS, Lora CM, Ackerson L, Cohan J, Kusek JW, Mercado A, Ojo A, Ricardo AC, Rosen LK, Tao K, Xie D, Feldman HI, Lash JP; CRIC and H-CRIC Study Groups. CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis. 2011; 58: 214-227. doi:10.1053/j. ajkd.2011.05.010 PubMed
79. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006; CD006257. PubMed
80. Ravera M, Ratto E, Vettoretti S, Parodi D, Deferrari G. Prevention and treatment of diabetic nephropathy: the program for irbesartan mortality and morbidity evaluation. J Am Soc Nephrol. 2005; 16 (Suppl 1): S48-S52. doi:10.1681/ASN.2004110957 PubMed
81. Barnett AH. Preventing renal complications in diabetic patients: the diabetics exposed to telmisartan and enalaprIL (DETAIL) study. Acta Diabetol. 2005; 42 (Suppl 1): S42-S49. doi:10.1007/s00592-005-0180-4 PubMed
82. Raji MA, Kuo YF, Salazar JA, Satish S, Goodwin JS. Ethnic differences in antihypertensive medication use in the elderly. Ann Pharmacother. 2004; 38: 209-214. doi:10.1345/aph.1D224 PubMed
83. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens. 2004; 17: 963-970. doi:10.1016/j.amjhyper.2004.06.001 PubMed
84. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006; 113: 213-221. doi:10.1161/CIRCULATIONAHA.105.542290 PubMed
85. de Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, Lash JP, Chan J, Remuzzi G, Brenner BM, Shahinfar S. Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int. 2006; 69: 1675-1682. doi:10.1038/sj. ki.5000326 PubMed
86. Coleman CI, Baker WL, Kluger J et al. Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease. University of Connecticut/Hartford Hospital Evidence-based Practice Center. 2009.
87. Kawazu S, Tomono S, Shimizu M, Kato N, Ohno T, Ishii C, Murata K, Watanabe T, Negishi K, Suzuki M, Takahashi M, Ishii J. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications. 1994; 8: 13-17. doi:10.1016/1056-87 27 (9 4)90005-1 PubMed
88. Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000; 23: 1478-1485. doi:10.2337/diacare. 23.10.1478 PubMed
89. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986. doi:10.1056/NEJM199309303291401 PubMed
90. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Di abetes Interventions and Complications (EDIC) study. JAMA. 2003; 290: 2159-2167. doi:10.1001/jama.290.16.2159 PubMed
91. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853. doi:10.1016/S0140-6736(98 )0 701 9-6 PubMed
92. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-393. doi:10.1056/NEJMoa021778 PubMed
93. Harris MI. Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the U.S. population. Diabetes Care. 1991; 14: 639-648. doi:10.2337/diacare.14.7.639 PubMed
94. West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R, Snyder R; Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001; 24: 1204-1209. doi:10.2337/diacare.24.7 .1 20 4 PubMed
95. Brown AF, Gerzoff RB, Karter AJ, Gregg E, Safford M, Waitzfelder B, Beckles GL, Brusuelas R, Mangione CM; TRIAD Study Group. Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Public Health. 2003; 93: 1694-1698. doi:10.2105/AJPH.93.10.1694 PubMed
96. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999; 22: 403-408. doi:10.2337/diacare.22.3.403 PubMed
97. Hertz RP, Unger AN, Ferrario CM. Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites. Am J Prev Med. 2006; 30: 103-110. doi:10.1016/j.ame pre.2 00 5.1 0. 015 PubMed
98. Bonds DE, Zaccaro DJ, Karter AJ, Selby JV, Saad M, Goff DC Jr. Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2003; 26: 1040-1046. doi:10.2337/diacare.26.4.1040 PubMed
99. Mainous AG III, Diaz VA, Koopman RJ, Everett CJ. Quality of care for Hispanic adults with diabetes. Fam Med. 2007; 39: 351-356. PubMed
100. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002; 136: 565-574. PubMed
101. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006; 144: 465-474. PubMed
102. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998; 158: 998-1004. doi:10.1001/archinte.158.9.998 PubMed
103. Sharma MD, Pavlik VN. Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001; 3: 41-45. doi:10.1046/j.1463-1326 .2 0 01.00113.x PubMed
104. Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006; 113: 647-656. doi:10.1161/CIRCULATIONAHA. 105.552737 PubMed
105. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with noninsulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997; 314: 783-788. doi:10.1136/bmj.314.7083.783 PubMed
106. Kramer H, Reboussin D, Bertoni AG, Marcovina S, Lipkin E, Greenway FL III, Brancati FL; Look Ahead Research Group. Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study. Diabetes Care. 2009; 32: 851-853. doi:10.2337/dc08-2059 PubMed
107. Afshinnia F, Wilt TJ, Duval S et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant, 2009.
108. Cueto-Manzano AM, Cortes-Sanabria L, Martinez-Ramirez HR, Rojas-Campos E, Barragan G, Alfaro G, Flores J, Anaya M, Canales-Munoz JL. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int Suppl. 2005; 68 (s97): S40-S45. doi:10.1111/j.1 5 2 3-1755.2005.09707.x PubMed
109. Haffner SM, Mitchell BD, Stern MP, Hazuda HP, Patterson JK. Public health significance of upper body adiposity for non-insulin dependent diabetes mellitus in Mexican Americans. Int J Obes Relat Metab Disord. 1992; 16: 177-184. PubMed
110. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res. 1997; 5: 16-23. PubMed
111. Monterrosa AE, Haffner SM, Stern MP, Hazuda HP. Sex difference in lifestyle factors predictive of diabetes in Mexican-Americans. Diabetes Care. 1995; 18: 448-456. doi:10.2337/diaca re. 18.4.448 PubMed
112. Haffner SM. Hyperinsulinemia as a possible etiology for the high prevalence of non insulin dependent diabetes in Mexican Americans. Diabete Metab. 1987; 13: 337-344. PubMed
113. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986; 315: 220-224. doi:10.1056/NEJM198607243150403 PubMed
114. Haffner SM, Miettinen H, Stern MP. Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab. 1996; 81: 1846-1851. doi:10.1210/jc.81.5.1846 PubMed
115. Gulli G, Ferrannini E, Stern M, Haffner S, De-Fronzo RA. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 1992; 41: 1575-1586. doi:10.2337/diabetes. 41.12.1575 PubMed
116. Belfiore F, Iannello S. Reduced insulin sensitivity in Mexican-Americans from San Antonio with elevated incidence of type 2 diabetes compared with Mexicans from Mexico City. Diabetes Care. 2002; 25: 937-938., author reply 938-939. doi:10.2337/diacare.25.5.937-a PubMed
117. Burke JP, Williams K, Haffner SM, Villalpando CG, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care. 2001; 24: 1573-1578. doi:10.2337/diacare.24.9.1573 PubMed
118. Finkelstein J, Joshi A, Hise MK. Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006; 48: 372-382. doi:10.1053/j.ajkd.200 6. 05. 0 13 PubMed
119. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003; 26: 3054-3060. doi:10.2337/diacare.26.11.3054 PubMed
120. Johnson L, Strich H, Taylor A, Timmermann B, Malone D, Teufel-Shone N, Drummond R, Woosley R, Pereira E, Martinez A. Use of herbal remedies by diabetic Hispanic women in the southwestern United States. Phytother Res. 2006; 20: 250-255. doi:10.1002/ptr.1820 PubMed
121. Ortiz BI, Shields KM, Clauson KA, Clay PG. Complementary and alternative medicine use among Hispanics in the United States. Ann Pharmacother. 2007; 41: 994-1004. doi:10.1345/aph.1H600 PubMed
122. Hunt LM, Arar NH, Akana LL. Herbs, prayer, and insulin. Use of medical and alternative treatments by a group of Mexican American diabetes patients. J Fam Pract. 2000; 49: 216-223. PubMed
123. Noel PH, Pugh JA, Larme AC, Marsh G. The use of traditional plant medicines for non-insulin dependent diabetes mellitus in South Texas. Phytother Res. 1997; 11: 512-517. doi:10.1002/(S IC I) 10 99-1573(199711)11:7 < 512::AID-PTR 149 > 3.0 .CO;2-H
124. Poss JE, Jezewski MA, Stuart AG. Home remedies for type 2 diabetes used by Mexican Americans in El Paso, Texas. Clin Nurs Res. 2003; 12: 304-323. doi:10.1177/1054773803256872 PubMed
125. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006; 12: 16-22. PubMed
126. Garrow D, Egede LE. National patterns and correlates of complementary and alternative medicine use in adults with diabetes. J Altern Complement Med. 2006; 12: 895-902. doi:10.1089/acm.2006.12.895 PubMed
127. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002; 25: 324-329. doi:10.2337/diacare.25.2.324 PubMed
128. Markell MS. Potential benefits of complementary medicine modalities in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2005; 12: 292-299. doi:10.1016/j.ackd.2005.03.004 PubMed
129. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82: 47-95. PubMed
130. West IC. Radicals and oxidative stress in diabetes. Diabet Med. 2000; 17: 171-180. doi:10.10 46/j.1 46 4-5491.2000.00259.x PubMed
131. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001; 17: 189-212. PubMed doi:10.1002/dmrr.196
132. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005; 7: 1040-1052. doi:10.1089/ars.2005.7.1040 PubMed
133. Parving HH, Mauer M, Ritz E. Diabetic Nephropathy, in Brenner & Rector's The Kidney, B.M. Brenner and S.A. Levine, Editors. Saunders Elsevier: Philadelphia, PA; 2008. p. 1265-1298.
134. Stoddard P, He G, Vijayaraghavan M, Schillinger D. Disparities in undiagnosed diabetes among United States-Mexico border populations. Rev Panam Salud Publica. 2010; 28: 198-206. doi:10.1590/S1020-49892010000900010 PubMed
135. Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005; 28: 2280-2288. doi:10.2337/diacare. 2 8.9. 2280 PubMed
136. Cowie CC, Eberhardt MS. Sociodemographic Characteristics of Persons with Diabetes, U.S.D.o.H.a.H. Services, Editor. The National Diabetes Information Clearinghouse (NDIC); 1995. p. 85-116.
137. Merriam PA, Tellez TL, Rosal MC, Olendzki BC, Ma Y, Pagoto SL, Ockene IS. Methodology of a diabetes prevention translational research project utilizing a community-academic partnership for implementation in an underserved Latino community. BMC Med Res Methodol. 2009; 9: 20. doi:10.1186/1471-2288-9-20 PubMed
138. Teufel-Shone NI, Drummond R, Rawiel U. Developing and adapting a family-based diabetes program at the U.S.-Mexico border. Prev Chronic Dis. 2005; 2: A20. PubMed
139. Correa-Rotter R, González-Michaca L. Early detection and prevention of diabetic nephropathy: a challenge calling for mandatory action for Mexico and the developing world. Kidney Int Suppl. 2005; 68 (s98): S69-S75. doi:10.1111/j. 15 23-17 55.2 005.09813.x PubMed
140. Thameem F, Puppala S, He X et al. Evaluation of gremlin 1 (GREM1) as a candidate susceptibility gene for albiminuria-related traits in Mexican Americans with type 2 diabetes mellitus. Metabolism. 2009; 58: 1496-1502.